Introduction to Jun 12 2026 This Week In Cardiology
Welcome to our comprehensive guide on Jun 12 2026 This Week In Cardiology. Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the ...
Jun 12 2026 This Week In Cardiology Comprehensive Overview
Listener feedback on valvular heart disease, statins and frailty, left atrial posterior wall ablation fails again, interpreting medical ... Time to quadruple therapy, the disappointing AVANT GUARD trial, PFA risks, the TREAT-PVC trial, and NSTEMI care in the frail ... A life-long treatment for high LDL, a VESALIUS subanalysis, tirzepatide beats semaglutide again, arrhythmia burden in
Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more ...
Summary & Highlights for Jun 12 2026 This Week In Cardiology
- Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, ...
- PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA ...
- Chemical cardioversion in the ED, HF monitoring, weight loss in AF, and surgical LAA excision are the topics John Mandrola, MD, ...
- Welcome to This
- Welcome to This
In summary, understanding Jun 12 2026 This Week In Cardiology gives us a better perspective.
